X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (16142) 16142
Publication (1040) 1040
Book Review (256) 256
Book Chapter (74) 74
Book / eBook (60) 60
Conference Proceeding (35) 35
Magazine Article (31) 31
Web Resource (13) 13
Dissertation (7) 7
Reference (5) 5
Journal / eJournal (2) 2
Paper (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (13406) 13406
fibrinolytic agents - therapeutic use (8461) 8461
male (7449) 7449
female (6373) 6373
index medicus (5894) 5894
middle aged (4684) 4684
aged (4323) 4323
animals (4018) 4018
fibrinolytic agents - administration & dosage (3622) 3622
treatment outcome (3253) 3253
fibrinolytic agents - pharmacology (3086) 3086
peripheral vascular disease (2863) 2863
adult (2819) 2819
fibrinolytic agents - adverse effects (2406) 2406
thrombolytic therapy (2246) 2246
hematology (2163) 2163
risk factors (2063) 2063
stroke (2027) 2027
tissue plasminogen activator - therapeutic use (2010) 2010
time factors (2007) 2007
thrombolysis (1978) 1978
cardiac & cardiovascular systems (1858) 1858
thrombosis (1827) 1827
aged, 80 and over (1610) 1610
stroke - drug therapy (1506) 1506
anticoagulants - therapeutic use (1441) 1441
clinical neurology (1384) 1384
therapy (1350) 1350
surgery (1338) 1338
thrombolytic therapy - methods (1320) 1320
rats (1289) 1289
retrospective studies (1287) 1287
myocardial infarction - drug therapy (1276) 1276
thrombosis - drug therapy (1237) 1237
tissue plasminogen activator - administration & dosage (1224) 1224
fibrinolysis (1201) 1201
pharmacology & pharmacy (1188) 1188
care and treatment (1108) 1108
anticoagulants (1104) 1104
tissue plasminogen activator (1033) 1033
blood coagulation - drug effects (1028) 1028
mortality (1004) 1004
heparin - therapeutic use (995) 995
platelet aggregation inhibitors - therapeutic use (995) 995
prospective studies (992) 992
heparin (948) 948
fibrinolytic agents (905) 905
dose-response relationship, drug (874) 874
tissue-plasminogen activator (861) 861
aspirin (859) 859
acute myocardial-infarction (857) 857
ischemia (856) 856
thrombosis - prevention & control (856) 856
medicine, general & internal (852) 852
acute disease (840) 840
neurosciences (837) 837
drug therapy, combination (832) 832
management (825) 825
medicine & public health (823) 823
brain ischemia - drug therapy (821) 821
drug therapy (819) 819
platelet aggregation - drug effects (807) 807
disease models, animal (800) 800
follow-up studies (792) 792
analysis (789) 789
acute ischemic-stroke (786) 786
prevention (774) 774
aspirin - therapeutic use (749) 749
hemorrhage - chemically induced (749) 749
rabbits (736) 736
risk (734) 734
trial (734) 734
mice (717) 717
thrombolytic therapy - adverse effects (700) 700
prognosis (678) 678
risk assessment (667) 667
health aspects (664) 664
neurology (660) 660
recombinant proteins - therapeutic use (658) 658
tissue plasminogen activator - adverse effects (640) 640
abridged index medicus (636) 636
cardiology (626) 626
thrombosis - etiology (624) 624
blood platelets - drug effects (623) 623
fibrinolysis - drug effects (622) 622
thromboembolism (609) 609
adolescent (596) 596
streptokinase - therapeutic use (596) 596
molecular-weight heparin (590) 590
thrombin (589) 589
hemorrhage (583) 583
cardiovascular (577) 577
electrocardiography (577) 577
heart attacks (577) 577
alteplase (574) 574
infusions, intravenous (568) 568
research (562) 562
myocardial infarction - therapy (554) 554
tomography, x-ray computed (539) 539
pulmonary embolism - drug therapy (538) 538
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Online Resources - Online (11) 11
Collection Dvlpm't (Acquisitions) - Vendor file (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
UofT at Mississauga - Stacks (2) 2
Gerstein Science - Periodical Stacks (1) 1
Mt Sinai Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (14865) 14865
German (344) 344
Russian (308) 308
French (210) 210
Chinese (116) 116
Italian (111) 111
Japanese (91) 91
Spanish (74) 74
Polish (54) 54
Danish (20) 20
Portuguese (17) 17
Ukrainian (16) 16
Czech (14) 14
Swedish (12) 12
Hungarian (11) 11
Norwegian (10) 10
Finnish (9) 9
Dutch (8) 8
Romanian (8) 8
Korean (6) 6
Turkish (6) 6
Bulgarian (5) 5
Hebrew (3) 3
Lithuanian (3) 3
Croatian (2) 2
Serbian (2) 2
Slovak (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2010, Volume 103, Issue 4, pp. 815 - 825
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 04/2007, Volume 97, Issue 4, pp. 581 - 586
Journal Article
Journal Article
Methods in Molecular Biology, ISSN 1064-3745, 2017, Volume 1646, pp. 217 - 225
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2015, Volume 10, Issue 10, p. e0140668
Journal Article
Journal Article
Journal of Thrombosis and Haemostasis, ISSN 1538-7933, 02/2010, Volume 8, Issue 2, pp. 331 - 340
Journal Article
Archives of Pharmacal Research, ISSN 0253-6269, 8/2014, Volume 37, Issue 8, pp. 1069 - 1078
Cudratricusxanthone A (CTXA), a natural bioactive compound extracted from the roots of Cudrania tricuspidata Bureau, is known to possess hepatoprotective,... 
Prenylated xanthone | Anticoagulant | Cudratricusxanthone A | Pharmacology/Toxicology | Fibrinolysis | Pharmacy | CHEMISTRY, MEDICINAL | VEIN ENDOTHELIAL-CELLS | XANTHONES | PLASMINOGEN-ACTIVATOR INHIBITOR | COAGULATION CASCADE | CUDRANIA-TRICUSPIDATA | PLATELETS | PHARMACOLOGY & PHARMACY | ROOT BARK | TYPE-1 | EXPRESSION | CONSTITUENTS | Human Umbilical Vein Endothelial Cells | Anticoagulants - administration & dosage | Humans | Male | Fibrinolytic Agents - blood | Xanthones - pharmacology | Fibrinolytic Agents - isolation & purification | Platelet Aggregation Inhibitors - blood | Xanthones - blood | Plasminogen Activator Inhibitor 1 - metabolism | Platelet Aggregation Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Platelet Aggregation - drug effects | Anticoagulants - isolation & purification | Cell Survival - drug effects | Xanthones - isolation & purification | Xanthones - administration & dosage | Platelet Aggregation Inhibitors - isolation & purification | Factor Xa - metabolism | Mice, Inbred ICR | Anticoagulants - blood | Fibrinolytic Agents - pharmacology | Animals | Blood Coagulation - drug effects | Anticoagulants - pharmacology | Plant Roots - chemistry | Moraceae - chemistry | Fibrinolytic Agents - administration & dosage | Mice | Thrombin - metabolism | Medical colleges | Fibrin | Medical examination | Polymerization | Drugstores | Thrombin | Anticoagulants (Medicine) | Blood | Cells
Journal Article